Bio-Pharm

Celltrion has received its first approval for a biosimilar of Prolia (denosumab), a treatment for osteoporosis. On…

Samsung Biologics has surpassed 5 trillion KRW in annual cumulative orders for the first time since its establishment.…

Medical AI company VUNO announced on the 19th that its AI-based chest X-ray diagnostic device, VUNO Med-Chest X-ray…

Lunit, a medical AI company, announced on the 18th that it has signed a strategic collaboration agreement with…

Celltrion announced on the 15th that it has acquired the Swiss pharmaceutical distribution company "iQone Healthcare…

"By the 2030s, I envision Alteogen joining the ranks of companies with annual revenue in the trillions of won. We’ll…

Hugel Inc., a leading global medical aesthetics company, said on Wednesday it had recently launched H.E.L.F. Global…

Alteogen is advancing in the development of the world’s first subcutaneous (SC) injection for antibody-drug…

For the first time since its founding, Hugel has exceeded 100 billion KRW in quarterly revenue and 50 billion KRW in…

Huons is set to expand its biopharmaceutical R&D and contract development and manufacturing organization (CDMO)…

The Korean Dementia Association has addressed safety concerns related to the upcoming domestic release of the…

Samsung Bioepis has surpassed its total annual revenue from last year within the first three quarters of 2023. The…

Boryung is getting closer to achieving 1 trillion KRW ($740 million) in annual sales for the first time, supported by…

Yuhan Corporation’s third-quarter operating profit has skyrocketed, primarily due to license revenue from its…

Following Samsung Biologics’ announcement of its third-quarter results, several securities firms have raised their…

SK bioscience announced that its quadrivalent cell-culture influenza vaccine, SkyCellflu Quadrivalent Pre-filled…

Samsung Biologics has made headlines again. On the 22nd, the company announced that it had signed a massive Contract…

It's been two and a half years since OCI became the largest shareholder of Bukwang Pharmaceutical, yet instead of…

Contrast-enhanced mammography (CEM) is gaining attention as a crucial method in the fight against breast cancer, the…

DongKook Pharmaceutical strengthens its cosmetics business by acquiring ReBom Cosmetics. On the 16th, DongKook…